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TO THE EDITOR
Null mutations in the epidermal barrier
protein filaggrin (FLG) cause ichthyosis
vulgaris (IV, Smith et al., 2006) and are
a major risk factor for eczema and other
atopic diseases (Palmer et al., 2006;
Baurecht et al., 2007; Brown et al.,
2008a; Henderson et al., 2008). About
10% of European patients are
heterozygous for such null mutations
(Sandilands et al., 2006), but clinical
details of their skin phenotype are
sparse. A recent study of 811 English
children reported that mild ichthyosis,
palmar hyperlinearity, and keratosis
pilaris were commoner in carriers of
null mutations (Brown et al., 2008a).
We report the effect of heterozygosity
for FLG null alleles, and age, on the
prevalence of simple subjective or
objective clinical features of ‘‘dry skin’’
in adults and elderly patients not
selected for inflammatory skin disease.
Patients referred for diagnosis of a
discrete skin lesion to dermatology
clinics in Glasgow were recruited in
two age cohorts: young adults 18–40
years (192 patients; 82 men, 110
women), and the elderly 60–75 years
(99 patients; 55 men, 44 women).
Patients were asked not to apply body
moisturizers for 48 hours before their
appointment; sunbed users or those
who had been on a sunny holiday
within 6 weeks were excluded. The
protocol was approved by the South
Glasgow Research Ethics Committee,
conformed to the Declaration of Hel-
sinki Principles, and written informed
consent was obtained. The study took
place in all months of the year, in a
climate without extreme variation in
humidity, and all assessments took
place before genotyping. A question-
naire asked patients whether they
considered they had dry skin (possible
responses, coded 0–3, were not at all, a
little, moderately, or a lot), sensitive
skin (same responses) and how often
they used a moisturizer for the body
(never, now and again, more than once
a week, or daily), and sought a history
of childhood eczema or other diseases.
Trained observers made objective as-
sessments of visible fine scale and of
roughness in each of three body sites
(volar forearms, lower legs, and lower
back), of keratosis pilaris (upper arms
only), and of increased palmar mark-
ings and texture. A simple scoring scale
for each parameter was used: absent
(0), just perceptible (1), obvious (2), and
marked (3). The total score of these
parameters (maximum 27) was used as
a summary measure of ‘‘dry skin’’.
DNA, extracted from whole blood
using standard procedures, was geno-
typed for four FLG null mutations
common in the UK (R501X, 2282del4,
R2447X, and S3247X) as described
(Palmer et al., 2006; Sandilands et al.,
2007) with minor refinements (Table
S1). Statistical comparisons were
made in 284 patients in whom all
four mutations were successfully
typed, between those wild-type se-
quence at all loci (wt) and patients
heterozygous for only one of the muta-
tions (null).
Of 284, 252 (89%) patients were
wild type for all four mutations; 29
(10.2%) were heterozygous for one null
mutation, and 3 (1%) were compound
heterozygotes, R501X/R2447X, 2282del4/
S3247X, and R2447X/S3247X. The fre-
quency of these alleles was consistent
with the previous UK data (Table S2;
Sandilands et al., 2007; Brown et al.,
2008b). Four patients in whom the
assessors commented on marked
scaling consistent with IV included all
three compound heterozygotes; the
fourth was heterozygous only for
R501X but on biopsy showed a reduced
granular layer, consistent with previous
immunohistochemical analysis indica-
tive of an undetected second null
mutation (Sandilands et al., 2007); for
financial reasons, this patient was not
subjected to full sequencing.
Questionnaire results are shown in
Figure 1a and Table S3. Women were
highly significantly more likely than
men to consider they had dry skin (39
vs 11%) or use body moisturizers
regularly (43 vs 7%). Heterozygous
carriers of null mutations were more
likely to think they had dry skinAbbreviation: FLG, filaggrin; IV, ichthyosis vulgaris
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Figure 1. Symptoms and signs of dry skin are more likely in carriers of null alleles. Effect of heterozygosity for one null mutation in filaggrin on (a) subjective dry
skin and history of eczema and other disorders and (b) the presence of clinical signs of dry skin. In each case the odds ratios (shown with 95% confidence
intervals) represent the likelihood of a heterozygous carrier displaying the feature, compared with individuals with wild-type sequence at all four polymorphisms
tested. No carriers gave a history of psoriasis, so the odds ratio has not been calculated.
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Figure 2. Total scores for signs of dry skin are increased in carries of null alleles. Population distribution of individual total scores for features of dry skin in 238
patients with (left) wild-type sequence at all four polymorphisms tested and (right) 27 patients carrying one null mutation in FLG and two compound
heterozygotes (the latter shown by *); note the 10-fold difference in scale. 18 patients typed, including two heterozygotes and one compound heterozygote, were
excluded from assessment of signs because they had used body moisturizer within 48 hours. The subject who scored 18 was thought clinically to have IV,
and granular layer was absent on biopsy. He may be carrying a second mutant allele not identified in this study.
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‘‘moderately’’ or ‘‘a lot’’ (Fisher’s exact
test; P¼0.024), to due principally men,
and not significant in women alone.
Use of body moisturizers twice a week
or more was commoner among carriers,
but again this finding was significant
only in men (P¼0.035). Self-perceived
sensitive skin (‘‘moderately’’ or ‘‘a lot’’)
was no more common among carriers.
Carriers were more likely to give a
history of childhood eczema
(P¼0.009), but asthma and hay fever
were not significantly more common in
this study. Trends to fewer cases of acne
and psoriasis in carriers were not
significant.
In the objective assessments, the
prevalence of fine scaling and rough-
ness of the skin, keratosis pilaris, and of
palmar hyperlinearity and roughness (a
score of 1 or more) were all increased
in carriers (Figure 1b). For most para-
meters this was significant by Fisher’s
exact test (Table S3). Distribution of
total skin signs in wild-type and carrier
populations is shown in Figure 2; 94%
of young non-carriers had a score of 4
or less and thus a total score 44 was
chosen to define clinical ‘‘dry skin’’. By
this criterion, using binary logistic
regression, heterozygous carriers were
more likely than non-carriers to have
dry skin (odds ratio 7.3, 95% confi-
dence interval 2.9–18.6, P¼0.00002;
P¼0.003 in each age cohort). Inde-
pendently of genotype, the elderly were
more likely to have dry skin than
younger adults (odds ratio 2.9, 95%
confidence interval 1.3–6.3, P¼0.007).
Seventy percent of young adult carriers
exhibited some features of dry skin (a
score of 1 or more in any parameter)
but so did 47% of young non-carriers.
All the older carriers had some
evidence of dry skin, but so did 70%
of non-carriers. In identifying young
carriers clinically, fine scale on the
legs was helpful (53% of carriers vs
22% of non-carriers) but most older
patients had scaling on the legs irre-
spective of genotype. In the latter
group, fine scaling on the arms, or
palmar hyperlinearity (63 vs 27%, and
50 vs 11%, respectively) provided
better opportunities to make a clinical
distinction.
In this adult population, ascertained
independently of dry or inflamed skin,
the prevalence of null mutations was
identical to previous UK populations
who had not been ascertained. We
chose to study patient perception and
simple clinically assessed surface
changes, to reflect the usage of the
term ‘‘dry skin’’ by patients and practi-
tioners in everyday life. This is less
objective than physiological correlates
of altered skin surface such as transepi-
dermal water loss and stratum corneum
hydration. Despite this, there was a
clear effect of FLG mutation on the
clinical measures. The finding that
heterozygous carriers have an in-
creased prevalence of dry skin is also
consistent with studies with potential
recruitment bias (for example, Novak
et al., 2008, ascertained for contact
eczema; Kezic et al., 2008, recruited by
advertisement). We also confirm the
recent population survey in English
schoolchildren showing increased dry
skin, an increased incidence of child-
hood eczema, and a surprisingly high
prevalence of clinical IV (Brown et al.,
2008a).
However, even with the loosest
criteria for dry skin, penetrance is at
most 70% in young patients and nearly
50% of non-carriers have some positive
findings. Signs such as keratosis pilaris
and palmar hyperlinearity are sugges-
tive but nonspecific, and though sum-
mary skin scores were highly
significantly different between groups
they have poor predictive values at an
individual level. Less than a third gave a
history of eczema. Thus, although null
mutations in FLG are a major contribut-
ing factor to clinical dry skin and
eczema in the population, additional
factors influence expression of these
phenotypes. These may include the
number of FLG repeats per allele, which
varies from 10 to 12 (Ginger et al.,
2005), or variations in the expression of
FLG or other protein or lipid components
of the cornified layer. The latter include
ceramides, whose decline may be
responsible for increasingly dry skin
with age (Rogers et al., 1996). Further
study of protein and lipid expression in
the skin is required to identify the
molecular correlates of clinical dry skin,
impaired barrier function, and predispo-
sition to eczema in carriers of FLG null
mutations.
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TO THE EDITOR
Circumscribed palmo-plantar hypoker-
atosis (CPH) is a recently described
keratoderma characterized by persis-
tent asymptomatic, well-circumscribed,
depressed macules on the palm or
sole skin developing after middle age
(Perez et al., 2002). The characteristic
pathological features are an abrupt
step-down in the cornified layer and
resulting hypokeratosis of the lesional
epidermis without notable changes
in the underlying dermis. Several
pathogeneses have been proposed, in-
cluding clonal epidermal malformation,
primary keratinizing disorder at the
granular and horny layers, trauma and
papilloma-virus infection. However,
insufficient biological observations
have been reported to verify the nature
of this unique keratoderma.
Here, we propose that the loss of
keratin 9 (K9) and connexin 26 (Cx26)
expression in lesional keratinocytes as a
pathogenetical alteration of CPH based
on immunohistochemical observation of
our two additional cases affecting the sole
and palm skin, respectively. The patients
gave their consent to this study, which
was approved by Kyoto University Hos-
pital and conducted in accordance with
the Declaration of Helsinki Principles.
Case 1
A 62-year-old Japanese man presenting
with a solitary, asymptomatic, well-
circumscribed, round, nonerythema-
tous macule on the plantar arch of the
right sole, which had persisted for 2
years (Figure 1a). The lesion had
increased in size gradually, and the
diameter was 12mm. Topical steroids
and antibiotics were of no benefit.
Bacterial cultures were negative.
Dermoscopic views using jelly immer-
sion showed regularly distributed whit-
ish spots with round pigmentation
corresponding to the pigmented acro-
syringeum (data not shown). Furrows
and ridges were obscure but main-
tained. Histological examination
showed an abrupt and substantial de-
crease in the thickness of the stratum
corneum (Figure 1b). The corneum in
the involved skin showed typical bas-
ket-wave orthokeratosis. The lesional
epidermis was thinner and its granular
layer was reduced when compared to
adjacent noninvolved skin. However,
lesional sweat glands did not show
these characteristic features. The acro-
syringeal structures, including thick
cornified and granular layers, remained
similar in appearance to the surround-
ing intact skin (Figure 1c). Multiple
slices detected no cornoid lamella.
Nuclear size and quality of cytoplasm
in keratinocytes from lesional skin was
subtly disrupted, but there was no
pleomorphism. There was no lympho-
cyte infiltration or dilated vessels in the
papillary dermis. Connective tissue in
the dermis looked normal on heama-
toxylin and eosin (HE) staining. The
density and shape of dermal fibroblasts
located beneath the affected epidermis
did not differ from those in adjacent
normal dermis. Immunohistochemical
examination revealed that K9 expres-
sion at the lesional epidermis dimin-
ished abruptly at the transition from
intact sole skin; however, the acrosyr-
ingeal keratinocytes scattered in the
hypokeratotic macula continued to
show strong expression of K9 (Figure
2a and b). In contrast, lesional kerati-
nocytes showed robust keratin 10 (K10)
expression, as compared to the subtle
K10 expression in the surrounding sole
epidermis (Figure 2c and d). Expression
of K6 and K16 showed no marked
difference between normal and lesional
skin (data not shown). Involucrin
and filaggrin showed slightly decreased
expression in the involved epidermis
when compared to the adjacent
normal skin (data not shown). The
expression of Cx26, which is known
to be abundant in the palm-plantar
keratinocytes, also diminished notably
at the hypokeratotic lesional keratino-
cytes. The acrosyringeal keratinocytes
exclusively retained Cx26 expression
(Figure 2e and f ).
The number of Ki-67- (antibody
against the cell proliferation marker
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